Tauopathies: new perspectives and challenges

Y Zhang, KM Wu, L Yang, Q Dong, JT Yu - Molecular neurodegeneration, 2022 - Springer
Background Tauopathies are a class of neurodegenerative disorders characterized by
neuronal and/or glial tau-positive inclusions. Main body Clinically, tauopathies can present …

Frontotemporal lobar degeneration

M Grossman, WW Seeley, AL Boxer, AE Hillis… - Nature Reviews …, 2023 - nature.com
Frontotemporal lobar degeneration (FTLD) is one of the most common causes of early-onset
dementia and presents with early social–emotional–behavioural and/or language changes …

Mental health care for older adults: recent advances and new directions in clinical practice and research

CF Reynolds 3rd, DV Jeste, PS Sachdev… - World …, 2022 - Wiley Online Library
The world's population is aging, bringing about an ever‐greater burden of mental disorders
in older adults. Given multimorbidities, the mental health care of these people and their …

Efficacy of repetitive transcranial magnetic stimulation in Parkinson's disease: a systematic review and meta-analysis of randomised controlled trials

W Zhang, B Deng, F Xie, H Zhou, JF Guo, H Jiang… - …, 2022 - thelancet.com
Background Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive form of
brain stimulation that positively regulates the motor and non-motor symptoms of Parkinson's …

A review of combined neuromodulation and physical therapy interventions for enhanced neurorehabilitation

A Evancho, WJ Tyler, K McGregor - Frontiers in human neuroscience, 2023 - frontiersin.org
Rehabilitation approaches for individuals with neurologic conditions have increasingly
shifted toward promoting neuroplasticity for enhanced recovery and restoration of function …

Therapy for Alzheimer's disease: Missing targets and functional markers?

M Stoiljkovic, TL Horvath, M Hajós - Ageing research reviews, 2021 - Elsevier
The development of the next generation therapy for Alzheimer's disease (AD) presents a
huge challenge given the number of promising treatment candidates that failed in trials …

A scoping review of neurodegenerative manifestations in explainable digital phenotyping

H Alfalahi, SB Dias, AH Khandoker… - npj Parkinson's …, 2023 - nature.com
Neurologists nowadays no longer view neurodegenerative diseases, like Parkinson's and
Alzheimer's disease, as single entities, but rather as a spectrum of multifaceted symptoms …

Digitalized transcranial electrical stimulation: a consensus statement

AR Brunoni, H Ekhtiari, A Antal, P Auvichayapat… - Clinical …, 2022 - Elsevier
Objective Although relatively costly and non-scalable, non-invasive neuromodulation
interventions are treatment alternatives for neuropsychiatric disorders. The recent …

Treatment for cognitive and neuropsychiatric non-motor symptoms in Parkinson's disease: current evidence and future perspectives

E Mantovani, C Zucchella, AA Argyriou… - Expert Review of …, 2023 - Taylor & Francis
Introduction Non-motor symptoms (NMS) affect patients with Parkinson's disease (PD) from
the prodromal to the advanced stages. NMS phenotypes greatly vary and have a huge …

Transcranial magnetic stimulation treatment in Alzheimer's disease: a meta-analysis of its efficacy as a function of protocol characteristics and degree of …

A Menardi, L Dotti, E Ambrosini, A Vallesi - Journal of Neurology, 2022 - Springer
Alzheimer's disease (AD) represents the most common type of neurodegenerative disorder.
Although our knowledge on the causes of AD remains limited and no curative treatments are …